Following treatment with Allocetra–OTS, most of these inflammatory immune-modulators, including IL-6, IFN-γ, IL-10, TNFR1, IP-10, MCP-3, and IL-7, gradually decreased to normal levels with resolution of COVID-19. The gene discussed is TNFRSF1A; the disease is COVID-19.